Analysts at Morgan Stanley downgrade Haemonetics Corporation
HAE from “equal weight” to “underweight.” The target price for HAE is set to $55.
HAE shares fell 1.08% to close at $63.18 on Friday.
More Analyst Ratings hereLoading...
Loading...
HAEHaemonetics Corp
$71.081.45%
Edge Rankings
Momentum
23.56
Growth
31.79
Quality
Not Available
Value
26.01
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
